IMPACT ON DRUG IMPURITY PROFILING WITH SUB 3 μM HPLC COLUMN PACKINGS

Chromatography

IMPACT ON DRUG IMPURITY PROFILING WITH SUB 3 μM HPLC COLUMN PACKINGS

05 Nov, 2008

Published over 17 years ago. See the latest and most current information on Chromatography.

Jason A. Anspach
1 min read
Download
One key analytical area where column loadability is a major concern is drug impurity profiling assays, where a large amount of the main component must be loaded onto the column in order to increase the detectability of trace contaminants. Typically it is necessary to quantitate the impurities at the 0.05 - 0.1% level compared to the main peak area. In this paper, we examine the loadability of commercially available sub 3 μm stationary phases, and investigate the role that media surface area has on loadability and how this impacts impurity-profiling assays.

Latest Articles

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Exhibitor registration opens for 2027 occupational safety and health trade fair in Düsseldorf
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow